GHK-Cu Capsules Canada — Capsules
Copper Tripeptide Complex
GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine with copper. This listing is for an encapsulated format supplied strictly for laboratory research.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine with copper. This listing is for an encapsulated format supplied strictly for laboratory research.
No candidate references were available for this entry, so the specific literature on this compound and this format is not characterised here. Statements about its activity, origin or research history have therefore been omitted rather than inferred.
Third-party tested for purity, ID, quantity.
Coming Soon
The certificate of analysis for this lot is being finalised and will be published here as soon as the lab returns it.
GHK-Cu is described by its name as a copper-bound tripeptide. Beyond that compositional description, no mechanism is asserted on this page, because no published sources were supplied against which such a description could be grounded.
Research endpoints that have been evaluated for this compound, and whether any of that work used an encapsulated oral format, could not be established from the material available. Researchers should consult primary literature directly.
The origin and development history of GHK-Cu is not documented in the material available for this page. No claim is made here about when, where or by whom it was first described or prepared.
Likewise, the development of the capsule format is not documented here. Any account of its research lineage would be speculation and has been left out.
No published research frameworks for this compound could be identified from the references available for this page. The research record as presented to us is empty, and nothing is characterised here in its place. This is a limitation of this page rather than a statement about the state of the scientific literature generally.
0 of the 2 areas below are addressed directly by a paper cited on this page.
No paper is cited on this page for GHK-Cu Capsules, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
No paper is cited on this page for GHK-Cu Capsules, so nothing supports this line of enquiry specifically. The heading describes where the compound is discussed in this category, not what has been shown about it.
No primary literature is cited on this page for GHK-Cu Capsules. Where a compound has little or no indexed research behind it, saying so is more useful than presenting a thin record as a full one.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for GHK-Cu Capsules, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
GHK-Cu Capsules is described across this category in connection with copper-peptide complex chemistry and tripeptide research compounds.
No primary literature is cited on this page for GHK-Cu Capsules, because none suitable for citation was identified. That is the finding, not an omission: where a compound has no indexed published research behind it, no claim about what it does in any system is supported — including the framing above. It is supplied strictly as a research material for laboratory use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Every lot of GHK-Cu Capsules is independently assayed before it is released, and the certificate for the lot shipped is published rather than summarised. Where a certificate for a current lot is not yet posted, the lot has not yet been released against it.
Researchers who buy GHK-Cu Capsules in Canada through Eppix Labs receive a batch-labelled vial whose certificate is published against that lot code, so the material can be matched to its analysis rather than to a generic specification.
GHK-Cu Capsules is supplied in capsule form, which removes the reconstitution step entirely: there is no vehicle to add, no reconstitution volume to record and no post-reconstitution stability window to track. What that leaves a laboratory to control is storage — capsule shells draw moisture from the air, so the container should be kept sealed and dry rather than decanted into an open vessel.
Because the material is already at its labelled quantity per capsule, batch verification carries more weight in this format than it does for powder: there is no point at which the researcher independently confirms mass by weighing. The measured content published for each lot is the figure that answers that question.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of GHK-Cu in capsule form. Independent third-party analysis verifies purity, identity, and net content per batch.
The container holds only the capsules. Any laboratory materials required for extraction, preparation, or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Related
Eppix Flash Sale −30%Capsules
PDE5 Inhibitor Research Compound Tadalafil is a small-molecule phosphodiesterase type 5 (PDE5) inhibitor supplied in capsule form for laboratory research. It is handled as a reference compound in controlled experimental and analytical settings.
$38.46$54.95CAD
Flash sale ends in
Eppix Flash Sale −30%Capsules
AMPA Receptor Potentiator TAK-653 is a small molecule described in the literature as an AMPA receptor positive allosteric modulator. It is supplied in capsule form strictly for laboratory research use.
$66.47$94.95CAD
Flash sale ends in
Eppix Flash Sale −30%Capsules
Unidentified Capsule Preparation SANA Capsules is supplied as a capsule-format research item. No molecular identity, sequence, or defined active constituent could be established for this designation from the available chemical records or published literature.
$66.47$94.95CAD
Flash sale ends in
Eppix Flash Sale −30%Capsules
Oral Non-Peptide GLP-1 Receptor Agonist Orforglipron is an orally available, non-peptide small molecule characterised as an agonist at the glucagon-like peptide-1 (GLP-1) receptor. It is supplied here in capsule form for laboratory research within controlled experimental environments.
$52.46$74.95CAD
Flash sale ends in
